Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Top Stories

TRUFFLE CAPITALCONGRATULATES SYMETIS ON ITS$435 MILLION DEFINITIVE PURCHASE AGREEMENTWITH BOSTON SCIENTIFIC

TRUFFLE CAPITALCONGRATULATES SYMETIS ON ITS$435 MILLION DEFINITIVE PURCHASE AGREEMENTWITH BOSTON SCIENTIFIC
  • Truffle Capital has been a leading historical investor of Symetis since its creation
  • Symetis is a leader in the field ofpercutaneous heart valve replacement solutions (TAVI)
  • Acquisition for $435 million in cash

Truffle Capital, a leading European venture capital firm aimed at creating young innovative companies and supporting their development, congratulates Symetis, leader in the field of percutaneous heart valve replacement solutions (TAVI), on its acquisition by Boston Scientific for $435 million[1]. Symetis’ IPO launched on Euronext Paris and very well received by the investment community, has been halted.

Truffle Capital has been an historical investor of Symetis since its creation and has been involved in all its development stages: R&D, clinical development, industrialization, CE-marking and marketing in Europe (€35 million in sales in 2016).

Philippe Pouletty MD., co-founder and Managing Director of Truffle Capital said, “The revolution of minimally-invasive interventional medicine is gaining momentum. New bioprosthetic devices and implants which make the patients treatment procedures faster, more accurate and more convenient, have mainly been developed by start-upscompanies targeting disruptive innovations, Truffle Capital’s strategic focus“. He added, “Disruptive medical devices at a commercial stage or in clinical development are often better valued by corporate players than by thestock market. This is especially the case for structural heart and orthopedics devices.

Truffle Capital is also co-founder and investor of Carmat (artificial heart), Epygon (mitral valve), Kephalios (adjustable mitral annuloplasty device) and Kardiosis (endoprosthesis for aortic aneurysm) in the field of cardiovascular devices; of Vexim (SpineJack® implant for vertebral fractures) in orthopedics; of Myopowers (artificial sphincter) in urology and of Théraclion (Echotherapy for tumors).

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post